Pages that link to "Q26752755"

The following pages link to Biomarkers and Targeted Therapy in Pancreatic Cancer (Q26752755):

Displaying 14 items.

• Evaluation of serum D-dimer, fibrinogen, and CA19-9 for postoperative monitoring and survival prediction in resectable pancreatic carcinoma (Q37655299) (← links)
• Mechanistic Evaluation and Translational Signature of Gemcitabine-induced Chemoresistance by Quantitative Phosphoproteomics Analysis with iTRAQ Labeling Mass Spectrometry (Q42374193) (← links)
• Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K. (Q50080994) (← links)
• PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. (Q50203906) (← links)
• Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. (Q53687842) (← links)
• mTOR signaling-related MicroRNAs and Cancer involvement. (Q55069878) (← links)
• Inflammation, not Cholesterol, Is a Cause of Chronic Disease. (Q55446683) (← links)
• Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells (Q58572503) (← links)
• Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma (Q89357388) (← links)
• αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model (Q90344693) (← links)
• Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives (Q91807444) (← links)
• Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles (Q92068202) (← links)
• Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice (Q93164954) (← links)
• Research progress on long non-coding RNAs and their roles as potential biomarkers for diagnosis and prognosis in pancreatic cancer (Q99711125) (← links)